CR11260A - Nuevos Cristales y procesos para elaborar 5-({[2-amino-3- (4-carbamoil-2,6-dimetilfenil)-propionil]-[1-(4-fenil-1h-imidazol -2-yl)-etil]-amino}-metil)-2-acido metoxibenzoico - Google Patents

Nuevos Cristales y procesos para elaborar 5-({[2-amino-3- (4-carbamoil-2,6-dimetilfenil)-propionil]-[1-(4-fenil-1h-imidazol -2-yl)-etil]-amino}-metil)-2-acido metoxibenzoico

Info

Publication number
CR11260A
CR11260A CR11260A CR11260A CR11260A CR 11260 A CR11260 A CR 11260A CR 11260 A CR11260 A CR 11260A CR 11260 A CR11260 A CR 11260A CR 11260 A CR11260 A CR 11260A
Authority
CR
Costa Rica
Prior art keywords
amino
dimethylphenyl
imidazol
propionyl
carbamoyl
Prior art date
Application number
CR11260A
Other languages
English (en)
Inventor
Luigi Anzalone
Frank J Villani
Allan Christopher
Penina Feibush
Barry Fegely
Original Assignee
Janssen Pharmaceutica Nv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=39926468&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=CR11260(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Janssen Pharmaceutica Nv filed Critical Janssen Pharmaceutica Nv
Publication of CR11260A publication Critical patent/CR11260A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/60—Salicylic acid; Derivatives thereof
    • A61K31/625—Salicylic acid; Derivatives thereof having heterocyclic substituents, e.g. 4-salicycloylmorpholine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/64—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with substituted hydrocarbon radicals attached to ring carbon atoms, e.g. histidine
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
    • C07B2200/00—Indexing scheme relating to specific properties of organic compounds
    • C07B2200/13—Crystalline forms, e.g. polymorphs
CR11260A 2007-07-09 2010-02-09 Nuevos Cristales y procesos para elaborar 5-({[2-amino-3- (4-carbamoil-2,6-dimetilfenil)-propionil]-[1-(4-fenil-1h-imidazol -2-yl)-etil]-amino}-metil)-2-acido metoxibenzoico CR11260A (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US94858407P 2007-07-09 2007-07-09

Publications (1)

Publication Number Publication Date
CR11260A true CR11260A (es) 2013-01-25

Family

ID=39926468

Family Applications (1)

Application Number Title Priority Date Filing Date
CR11260A CR11260A (es) 2007-07-09 2010-02-09 Nuevos Cristales y procesos para elaborar 5-({[2-amino-3- (4-carbamoil-2,6-dimetilfenil)-propionil]-[1-(4-fenil-1h-imidazol -2-yl)-etil]-amino}-metil)-2-acido metoxibenzoico

Country Status (25)

Country Link
US (7) US7994206B2 (es)
EP (1) EP2176234B1 (es)
JP (5) JP5702140B2 (es)
KR (2) KR101590596B1 (es)
CN (3) CN105111149A (es)
AU (1) AU2008275270C1 (es)
BR (1) BRPI0813632A2 (es)
CA (1) CA2695126C (es)
CO (1) CO6260079A2 (es)
CR (1) CR11260A (es)
EA (1) EA020024B1 (es)
EC (1) ECSP109863A (es)
ES (1) ES2567077T3 (es)
HK (1) HK1141519A1 (es)
HU (2) HUE028538T2 (es)
IL (1) IL203081A (es)
MX (1) MX339569B (es)
MY (1) MY174681A (es)
NI (1) NI201000001A (es)
NZ (1) NZ582420A (es)
PH (1) PH12016502561A1 (es)
SG (1) SG185941A1 (es)
UA (1) UA104713C2 (es)
WO (1) WO2009009480A2 (es)
ZA (1) ZA201000921B (es)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7412462B2 (en) 2000-02-18 2008-08-12 Burnside Acquisition, Llc Data repository and method for promoting network storage of data
WO2009009480A2 (en) * 2007-07-09 2009-01-15 Janssen Pharmaceutica N.V. Novel crystals and process of making 5-({[2-amino-3-(4-carbamoyl-2,6-dimethyl-phenyl)-propionyl]-[1-(4-phenyl-1h-imidazol-2-yl)-ethyl]-amino}-methyl)-2-methoxy- benzoic acid
US9675587B2 (en) * 2013-03-14 2017-06-13 Allergan Holdings Unlimited Company Opioid receptor modulator dosage formulations
US10314819B2 (en) 2015-07-23 2019-06-11 Teva Pharmaceuticals International Gmbh Solid state forms of Eluxadoline
WO2017114446A1 (zh) * 2015-12-31 2017-07-06 苏州晶云药物科技有限公司 艾沙度林的新晶型及其制备方法
EP3272741A1 (en) 2016-07-21 2018-01-24 Euticals S.P.A. New stable solvate crystalline forms of eluxadoline
US20190177281A1 (en) * 2016-05-03 2019-06-13 Sromovasam THIRUMALAI RAJAN Process for the preparation of 5-[[[(2s)-2-amino-3-[4-(aminocarbonyl)-2,6-dimethylphenyl]-1-oxopropyl] [(1s)-1-(4-phenyl-1h-imidazol-2-yl)ethyl]amino] methyl-2-methoxybenzoic acid and its polymorphs thereof
US10822308B2 (en) * 2016-06-23 2020-11-03 Sun Pharmaceutical Industries Limited Processes for the preparation of eluxadoline
WO2018020450A2 (en) 2016-07-28 2018-02-01 Lupin Limited Process for the preparation of eluxadoline
CZ2016548A3 (cs) 2016-09-07 2018-03-14 Zentiva, K.S. Pevné formy eluxadolinu
WO2018047131A1 (en) * 2016-09-09 2018-03-15 Sun Pharmaceutical Industries Limited Amorphous eluxadoline
EP3515434A4 (en) 2016-09-20 2020-02-26 Sun Pharmaceutical Industries Limited METHOD FOR PRODUCING ELUXADOLIN
WO2018069770A1 (en) * 2016-10-14 2018-04-19 Allergan Holdings Unlimited Company Methods of treatment using eluxadoline
WO2018138272A1 (en) 2017-01-27 2018-08-02 Quimica Sintetica, S. A. Eluxadoline crystalline form and process for the preparation thereof
US10738013B2 (en) 2017-01-27 2020-08-11 Quimica Sintetica, S.A. Eluxadoline crystalline forms and processes for their preparation
WO2018198101A2 (en) * 2017-04-25 2018-11-01 Sun Pharmaceutical Industries Limited Processes for the preparation of crystalline form of eluxadoline
WO2019008604A1 (en) 2017-07-07 2019-01-10 Cipla Limited NEW FORMS OF MU-OPIOID RECEPTOR AGONIST
CA3018321A1 (en) 2017-09-25 2019-03-25 Apotex Inc. Novel crystalline form of eluxadoline
US10298921B1 (en) * 2018-02-27 2019-05-21 Looking Glass Factory, Inc. Superstereoscopic display with enhanced off-angle separation
WO2020039333A1 (en) 2018-08-20 2020-02-27 Allergan Holdings Unlimited Company Polymorphs of 5-({[2-amino-3-(4-carbamoyl-2,6-dimethyl-phenyl)-propionyl]-[1-(4-phenyl-1h-imidazol-2-yl)-ethyl]-amino}-methyl)-2-methoxy-benzoic acid
US20230118152A1 (en) * 2020-03-30 2023-04-20 Allergan Holdings Unlimited Company Forms of 5-({[2-amino-3-(4-carbamoyl-2,6-dimethyl-phenyl)-propionyl]-[1-(4-phenyl-1h-imidazol-2-yl)-ethyl]-amino}-methyl)-2-methoxy-benzoic acid

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2003065441A (ja) * 2001-08-28 2003-03-05 Japan Matekkusu Kk パッキン材料及びこの材料を用いたグランドパッキン
SI1725537T1 (sl) 2004-03-15 2011-11-30 Janssen Pharmaceutica Nv Nove spojine kot modulatorji opioidnih receptorjev
MX2007011409A (es) 2005-03-14 2008-02-22 Johnson & Johnson Procedimiento de preparacion de moduladores opioides.
WO2009009480A2 (en) 2007-07-09 2009-01-15 Janssen Pharmaceutica N.V. Novel crystals and process of making 5-({[2-amino-3-(4-carbamoyl-2,6-dimethyl-phenyl)-propionyl]-[1-(4-phenyl-1h-imidazol-2-yl)-ethyl]-amino}-methyl)-2-methoxy- benzoic acid

Also Published As

Publication number Publication date
MY174681A (en) 2020-05-07
ZA201000921B (en) 2011-04-28
CA2695126C (en) 2018-10-30
IL203081A (en) 2016-09-29
JP2010533191A (ja) 2010-10-21
US20110263868A1 (en) 2011-10-27
US8859604B2 (en) 2014-10-14
NI201000001A (es) 2010-07-22
WO2009009480A3 (en) 2009-03-12
AU2008275270C1 (en) 2014-04-17
US20140221444A1 (en) 2014-08-07
NZ582420A (en) 2011-11-25
US20090018179A1 (en) 2009-01-15
JP2018123144A (ja) 2018-08-09
AU2008275270A1 (en) 2009-01-15
HUS1700011I1 (hu) 2017-04-28
US20160354389A1 (en) 2016-12-08
US20150099724A1 (en) 2015-04-09
US20140011851A1 (en) 2014-01-09
US8609865B2 (en) 2013-12-17
HK1141519A1 (zh) 2010-11-12
CN111620823A (zh) 2020-09-04
KR101590596B1 (ko) 2016-02-01
US8691860B2 (en) 2014-04-08
SG185941A1 (en) 2012-12-28
CN105111149A (zh) 2015-12-02
EP2176234B1 (en) 2016-01-27
KR20150080006A (ko) 2015-07-08
JP5852625B2 (ja) 2016-02-03
AU2008275270B2 (en) 2013-10-10
EP2176234A2 (en) 2010-04-21
US20160015724A1 (en) 2016-01-21
US7994206B2 (en) 2011-08-09
WO2009009480A2 (en) 2009-01-15
JP6321690B2 (ja) 2018-05-09
JP2014144946A (ja) 2014-08-14
US9115091B2 (en) 2015-08-25
KR101690161B1 (ko) 2016-12-27
US9789125B2 (en) 2017-10-17
US9364489B2 (en) 2016-06-14
UA104713C2 (ru) 2014-03-11
MX339569B (es) 2016-05-31
PH12016502561A1 (en) 2017-09-04
JP2015129154A (ja) 2015-07-16
CA2695126A1 (en) 2009-01-15
EA201070116A1 (ru) 2010-06-30
JP2016128433A (ja) 2016-07-14
EA020024B1 (ru) 2014-08-29
ES2567077T3 (es) 2016-04-19
ECSP109863A (es) 2010-02-26
KR20100043210A (ko) 2010-04-28
JP5702140B2 (ja) 2015-04-15
CO6260079A2 (es) 2011-03-22
HUE028538T2 (en) 2016-12-28
CN101730685A (zh) 2010-06-09
BRPI0813632A2 (pt) 2014-12-23
JP5870220B2 (ja) 2016-02-24

Similar Documents

Publication Publication Date Title
CR11260A (es) Nuevos Cristales y procesos para elaborar 5-({[2-amino-3- (4-carbamoil-2,6-dimetilfenil)-propionil]-[1-(4-fenil-1h-imidazol -2-yl)-etil]-amino}-metil)-2-acido metoxibenzoico
CR20110260A (es) Forma de dosificación farmacéutica que comprende nifedipino o nisoldipino y un antagonista de angiotensina ii y/o un diurético
DK2114873T3 (da) N-[3-brom-4-(3-[18f]fluorpropoxy)-benzyl]-guanidin til billeddannelse af innervation af hjertet
LTC2404919I2 (lt) Heterociklinis junginys, tinkamas panaudoti kaip ATP-rišančių kasečių transporterių moduliatorius
BRPI0818571A2 (pt) Cartucho para um biossensor, e, método para fabricar um cartucho
DK2035396T3 (da) Triazolforbindelser der modulerer hsp90-aktivitet
ZA201101891B (en) The salts of n-[4-(1-cyanocyclopentyl)phenyl]-2-(4-pyridyl methyl)amino-3-pyridinecarboxamide
IL229395A0 (en) Adjusted release of 4-methyl-3-[[4-(3-pyridinyl)-2-pyrimidinyl]amino]-4)-5-n-methyl-h1 imidazol-1-yl)-3-(trifluoromethyl)phenyl] Benzamide is dissolved using organic acids
BRPI0814153A2 (pt) "método para preparar um composto e composto"
BR122016010655B8 (pt) misturas fungicidas que compreendem um composto (i) selecionado de n-(3',4', 5'-trifluorobifenil-2-il)-3-difluorometil-1-metil-1h-pirazol-4-carboxamida, isopirazam e pentiopirad, e um fungicida adicional (ii) selecionado de ipconazol e difenoconazol e método para controlar pragas
DK3031825T3 (da) Immunbaserede aktivitetsassays for botulinum-toxin serotype a
BRPI0905956A2 (pt) Método de determinação de banda de frequência característica de uma doença cardíaca, método para a detecção de doenças cardíacas, dispositivo programável e conjunto de instruções em meio legível por computador
SE0801744L (sv) Övervakning av epileptiform aktivitet
DK2086940T3 (da) Fumaratsalt af (alfa- s, beta-r)-6-brom-alfa-[2-(dimethylamino)-ethyl]-2-methoxy-alfa-1-naphthalenyl-beta-phenyl-3-quinolinethanol
NO20064750L (no) Overvaking av akkumulator-bank
DE602006018910D1 (de) 1-(imidazolin-2-yl)amino-1,2-diphenylethan-verbindungen zur bekämpfung von tierpestkrankheiten
IL209815A0 (en) Solid forms of (1r,2s,3r)-1-(2-(isoxazol-3-yl)-1h-imidazol-4-yl)butane-1,2,3,4-tetraol and methods of their use
EP2314573A4 (en) CROSS-LINKED DIPHENYLSULPHONE COMPOUND, COLOR DEVELOPMENT SUBSTANCE FOR THERMAL RECORDING AND MATERIAL FOR THERMAL RECORDING
FI20086223A0 (fi) Transponderi, transponderisarja, menetelmä transponderin asettamiseksi ja transponderin käsittävä tuote
FI20075264A0 (fi) Heterosykliset fenyylikarbamaatit uusina FAAH-inhibiittoreina
BRPI0923764A2 (pt) colheitadeira, e, método para colher mudas
HK1133309A1 (en) Method for managing a bad block of a flash memory medium
FR2919487B1 (fr) Devidoir pour bandelette chirurgicale
PL380178A1 (pl) Sposób wytwarzania chlorowodorku 2-[(2, 3, 4-trihydroksyfenylo) metylo] hydrazydu D, L-seryny
CL2007001691A1 (es) Metodo para hacer n-hidroxi-3-(4(((2-(2-metil-1h-indol-3-il)etil)amino)metil)fenil)-2e-2-propenamida.

Legal Events

Date Code Title Description
FA Abandonment or withdrawal (granting procedure)